Filing Details
- Accession Number:
- 0001576280-25-000193
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-20 17:26:39
- Reporting Period:
- 2025-06-17
- Filing Date:
- 2025-06-20
- Accepted Time:
- 2025-06-20 17:26:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1576280 | Guardant Health Inc. | GH | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1336504 | T Ian Clark | 3100 Hanover Street Palo Alto CA 94304 | Yes | No | No | No |
Transaction Summary
| Sold: | 6,672 shares | Avg. Price: $48.38 | Total Value: $322,818.72 |
| Number of Shares After Transactions: | 9,851 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-06-17 | 6,672 | $48.38 | 9,851 | No | 4 | S | Indirect | By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2025-06-18 | 6,833 | $0.00 | 6,833 | $50.57 |
| Common Stock | Restricted Stock Units | Acquisiton | 2025-06-18 | 5,092 | $0.00 | 5,092 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 6,833 | 2035-06-18 | No | 4 | A | Direct | |
| 5,092 | No | 4 | A | Direct |
Footnotes
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.38 to $48.41 per shares, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The stock option vests in full on the one-year anniversary of the grant date, June 18, 2025 or the date of the next year annual stockholders meeting, whichever is earlier.
- The restricted stock units vest in full on the one-year anniversary of the grant date, June 18, 2025 or the date of the next year annual stockholders meeting, whichever is earlier.
- Not applicable for Restricted Stock Units.
Billionaire Hedge Funds
